← Open Payments lookup

MICHELLE DIMAURO: Open Payments

NPI 1760935373 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,632 in 88 payments from 14 companies in 2025. Trend: 2023 $1,833 · 2024 $1,842 · 2025 $1,632

Food & beverage: $1,632
CompanyPaymentsAmount
GlaxoSmithKline, LLC.30$336
AstraZeneca Pharmaceuticals LP12$299
GENZYME CORPORATION8$215
Amgen Inc.9$166
Novartis Pharmaceuticals Corporation7$141
Regeneron Healthcare Solutions, Inc.7$138
CSL Behring4$89
Takeda Pharmaceuticals U.S.A., Inc.3$86
ARS Pharmaceuticals Operations, Inc.2$39
Optinose US, Inc.2$38

Products named: DUPIXENT, NUCALA, TEZSPIRE, AIRSUPRA, Rhapsido, Andembry, BREZTRI, NEFFY.

Industry payments across CT — which companies pay providers there.